These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 17669543)

  • 1. Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum.
    Tarragó-Trani MT; Storrie B
    Adv Drug Deliv Rev; 2007 Aug; 59(8):782-97. PubMed ID: 17669543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a COP-I-independent transport route from the Golgi complex to the endoplasmic reticulum.
    Girod A; Storrie B; Simpson JC; Johannes L; Goud B; Roberts LM; Lord JM; Nilsson T; Pepperkok R
    Nat Cell Biol; 1999 Nov; 1(7):423-30. PubMed ID: 10559986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transport of protein toxins into cells: pathways used by ricin, cholera toxin and Shiga toxin.
    Sandvig K; van Deurs B
    FEBS Lett; 2002 Oct; 529(1):49-53. PubMed ID: 12354612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Passage through the Golgi is necessary for Shiga toxin B subunit to reach the endoplasmic reticulum.
    McKenzie J; Johannes L; Taguchi T; Sheff D
    FEBS J; 2009 Mar; 276(6):1581-95. PubMed ID: 19220458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP.
    Sandvig K; Ryd M; Garred O; Schweda E; Holm PK; van Deurs B
    J Cell Biol; 1994 Jul; 126(1):53-64. PubMed ID: 8027186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery?
    Medina-Kauwe LK
    Adv Drug Deliv Rev; 2007 Aug; 59(8):798-809. PubMed ID: 17707545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum.
    Sandvig K; Garred O; Prydz K; Kozlov JV; Hansen SH; van Deurs B
    Nature; 1992 Aug; 358(6386):510-2. PubMed ID: 1641040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of Shiga toxin B-subunit to retrograde transport route in association with detergent-resistant membranes.
    Falguières T; Mallard F; Baron C; Hanau D; Lingwood C; Goud B; Salamero J; Johannes L
    Mol Biol Cell; 2001 Aug; 12(8):2453-68. PubMed ID: 11514628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct pathway from early/recycling endosomes to the Golgi apparatus revealed through the study of shiga toxin B-fragment transport.
    Mallard F; Antony C; Tenza D; Salamero J; Goud B; Johannes L
    J Cell Biol; 1998 Nov; 143(4):973-90. PubMed ID: 9817755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy.
    Luginbuehl V; Meier N; Kovar K; Rohrer J
    Biotechnol Adv; 2018; 36(3):613-623. PubMed ID: 29432805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells.
    Warnier M; Römer W; Geelen J; Lesieur J; Amessou M; van den Heuvel L; Monnens L; Johannes L
    Kidney Int; 2006 Dec; 70(12):2085-91. PubMed ID: 17063173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrograde transport of protein toxins through the Golgi apparatus.
    Sandvig K; Skotland T; van Deurs B; Klokk TI
    Histochem Cell Biol; 2013 Sep; 140(3):317-26. PubMed ID: 23765164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endocytosis and intracellular sorting of ricin and Shiga toxin.
    Sandvig K; van Deurs B
    FEBS Lett; 1994 Jun; 346(1):99-102. PubMed ID: 8206167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocytosis and retrograde transport of Shiga toxin.
    Sandvig K; Bergan J; Dyve AB; Skotland T; Torgersen ML
    Toxicon; 2010 Dec; 56(7):1181-5. PubMed ID: 19951719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosphingolipid requirements for endosome-to-Golgi transport of Shiga toxin.
    Raa H; Grimmer S; Schwudke D; Bergan J; Wälchli S; Skotland T; Shevchenko A; Sandvig K
    Traffic; 2009 Jul; 10(7):868-82. PubMed ID: 19453975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrograde transport of KDEL-bearing B-fragment of Shiga toxin.
    Johannes L; Tenza D; Antony C; Goud B
    J Biol Chem; 1997 Aug; 272(31):19554-61. PubMed ID: 9235960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways followed by ricin and Shiga toxin into cells.
    Sandvig K; Grimmer S; Lauvrak SU; Torgersen ML; Skretting G; van Deurs B; Iversen TG
    Histochem Cell Biol; 2002 Feb; 117(2):131-41. PubMed ID: 11935289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that the transport of ricin to the cytoplasm is independent of both Rab6A and COPI.
    Chen A; AbuJarour RJ; Draper RK
    J Cell Sci; 2003 Sep; 116(Pt 17):3503-10. PubMed ID: 12865434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endocytosis, intracellular transport, and cytotoxic action of Shiga toxin and ricin.
    Sandvig K; van Deurs B
    Physiol Rev; 1996 Oct; 76(4):949-66. PubMed ID: 8874490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of Rab22a hampers the transport between endosomes and the Golgi apparatus.
    Mesa R; Magadán J; Barbieri A; López C; Stahl PD; Mayorga LS
    Exp Cell Res; 2005 Apr; 304(2):339-53. PubMed ID: 15748882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.